Windtree Therapeutics Secures $857,000 Convertible Note Financing for CommLoan Acquisition
I'm PortAI, I can summarize articles.
Windtree Therapeutics Inc. has secured $857,000 through senior convertible promissory notes for its planned acquisition of CommLoan Inc. The notes, maturing in 2026, have a 10% annual interest rate. Proceeds will advance $450,000 to CommLoan and retain $150,000 for corporate purposes. The agreement includes prepayment provisions and a 4.99% beneficial ownership limit for the investor. This information was published by Windtree Therapeutics via the SEC's EDGAR system.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments